The lung alveolar surface is composed of types I and II 
Introduction
Pulmonary alveoli are lined by types I and II epithelial cells. The extremely attenuated type I cells cover 90% of the surface as a simple, nonstratified epithelium and often undergo necrosis during acute lung injury (1) . After (2, 3) . During this process of in vivo alveolar reepithelialization the type II cells appear to migrate, spread, and proliferate on a matrix containing fibronectin (4, 5) . This observation is consonant with previous investigations that have demonstrated that a provisional fibronectin matrix is formed beneath epidermal cells (6) (7) (8) and corneal epithelial cells (9) during reepithelialization of cutaneous and corneal wounds, respectively.
These in vivo observations indicate that fibronectin is a suitable, if not critical, substrate for reepithelialization presumably by providing the right quality and quantity of adhesiveness for migrating epithelial cells. However, some previous in vitro investigations have suggested that fibronectin lacks the ability to mediate epithelial cell adhesion (10) (11) (12) . Nevertheless, since the in vivo data suggest that fibronectin does play a role in reepithelialization, we sought to determine whether isolated alveolar type II epithelial cells would adhere to purified fibronectin. In this report we demonstrate that purified human plasma fibronectin mediates type II cell adherence in vitro and that this adherence occurs at or near the previously characterized fibroblastic cell-attachment domain of fibronectin.
Methods
Isolation of rat alveolar type II cells. Type II cells were freed from rat lung by tissue dissociation with porcine pancreatic elastase and were partially purified by density gradient centrifugation as described previously (13, 14) . The specific-pathogen-free rats used in this study were obtained from Bantam Kingman, Walnut Creek, CA. Type II cells isolated by these techniques and placed into primary cultures have been shown to synthesize and secrete pulmonary surface active material (15) . Primary isolates were used for all the adherence assays described in this report.
Proteins. Human plasma fibronectin (FN)' was purified by the method of Furie and Rifkin (16) and after reduction gave two bands at -220,000 apparent mol wt on sodium dodecyl sulfate 5% polyacrylamide gel electrophoresis (SDS-PAGE). Human plasma fibrinogen (FG) was purified as previously described by Clark et al. (17) . Laminin (LM) and type IV collagen were purified from mouse EHS sarcoma as previously described (18, 19) . These proteins were either kindly provided by Dr. George Martin or purchased from Bethesda Research Laboratories (Frederick, MD).
Preparations from both sources gave identical patterns on SDS-PAGE and essentially the same results in adherence assays. Type I and III calf skin collagen was obtained from Worthington Laboratories (Freehold, NJ) or Collagen Corporation (Palo Alto, CA). Both preparations contained -95% type I collagen and 5% type III collagen and both gave similar results in adherence assays. Fetal calf serum (FCS) (Flow Laboratories, McLean, VA) used for type II cell adherence assays were depleted of fibronectin by passage over a gelatin-Sepharose 4B affinity column (20) . Complete fibronectin depletion was monitored by reduced SDS-PAGE and by inhibition enzyme-linked immunosorbent assay (ELISA) technique.
Preparation ofplates for adherence assays. Protein-coated wells for adherence assays were prepared by adding 50 ,u of a 100-j,g/ml protein (see above) in phosphate-buffered saline (PBS), pH 7.4, to bacteriologic plastic, 6 mm diameter, flat-bottom microtiter wells (Linbro Scientific, Hamden, CT) and incubating for 2 h at 22°C (21, 22) . Since some plastic protein-binding sites may still be available after application of the first protein coat, we added 50 ,l of 20 mg/ml human serum albumin (HSA) (Calbiochem-Behring Corp., La Jolla, CA) in PBS to each well and incubated for an additional 2 h at 22°C to block these sites (23) . In some wells, a third solution of 100 ,ug/ml FN or 100 ug/ml LM was added as above for surface adsorption. Since plastic protein-binding sites were blocked by HSA, these final proteins should interact with first coat proteins to become bound in the wells. Wells were washed between coatings three times with PBS and could be stored in PBS for up to 24 h at 4°C without effect on adherence assays. For blockdng experiments, antibodies were added to the coated wells and incubated overnight at 4°C. Plates incubated with polyclonal antibodies were washed and used immediately, whereas plates containing monoclonal antibodies were used with the antibodies still present.
ELISA. An indirect inhibition ELISA (24) Modification of ELISA to determine protein surface density. The inhibition ELISA was used to determine the amount of FN and LM adsorbed onto the bacteriologic plastic used for type II cell adherence assays. Various concentrations ofFN or LM were added to bacteriologic plastic, 24-well (each well is 16 mm diam), flat-bottom plates (Linbro Scientific) in the same volume to surface ratios as described for the 6-mm diam, flat-bottom wells in the previous section. After the blocking step with albumin, antibodies to either FN at a 1:20,000 dilution, or LM at a 1:8,000 dilution, were added to the wells. The plates were incubated overnight at 4°C, allowing the antibodies in solution to complex with the antigen adsorbed onto the wells. The next day residual antibodies were transferred from the adherence assay plates to ELISA assay plates. The amount ofantibody bound was quantitated as described above. The amount of protein adsorbed onto the adherence assay plates was determined by comparing the reduction in antibody concentration that occurred after preincubation with protein-coated adherence assay plates to the reduction in antibody concentration that occurred when antibodies were preincubated with known amounts of protein in solution. Wells with larger surface areas were needed in the ELISA assay so that the total quantity of adsorbed protein was detectable. Since the polystyrene plastic used to produce the 24-well plates and the microtiter plates was identical, we assumed that the nanogram per square millimeter adsorbed protein derived from the inhibition ELISA assays in 24-well plates was identical to the surface density of adsorbed protein in the microtiter plates.
Adherence assays. Primary isolates of rat alveolar type II cells for adherence assays were washed twice in Hanks' balanced salt solution without calcium or magnesium, counted and plated into precoated wells as 100-Ml aliquots of6 X I0O cells/ml in Eagle's minimal essential medium (Flow Laboratories) and 10% fibronectin-depleted fetal calf serum (FCS-FN). All assays except the time course study and the monoclonal antibody blocking study were incubated for 24 h in 95% air, 5% C02, and 100% humidity at 37°C.
In most assays after nonadherent cells were rinsed free, nuclei of attached cells were harvested in a solution of Isoton (Fisher Scientific, Englewood, CO) and Zapoglobin (Coulter Diagnostic, Houston, TX)
Fibronectin Mediates Alveolar Type II Cell Adherenceand counted on a Coulter Counter (25) . The total number ofcells added to microtiter wells was counted prior to plating. Percent adherence was calculated by dividing the counts harvested by total counts added to each well X 100. In assays involving antibodies, protein-coated plates incubated with antibodies alone gave high background particle counts on the Coulter secondary to antigen-antibody aggregates preventing the use of this counting technique. Thus, in antibody blocking experiments direct visual counts of adherent cells were determined. After the cell adherence incubation period, plates were rinsed, fixed in cold methanol for 5 min and stained for 30 min with Giemsa stain diluted 1:10 (Fisher). The plates were rinsed again, dried, and cells quantified by counting 10 random, 1.7 mm2 fields per well. Percent baseline adherence was calculated by dividing the cell counts from the wells containing antibody by the cell counts from wells with no antibodies X 100.
Antibodies for ELISA and blocking experiments. Antiserum to FN was raised in rabbits and antiserum to LM was raised in sheep according to the methods of Crowle (26) . Antibodies were purified by DEAE chromatography and (NH4)2SO4 precipitation of antiserum (27) . Anti-FN antibodies were further purified by affinity absorption with FN-free serum and FG bound to 4B Sepharose. These antibodies showed no crossreactivity by immunoprecipitation reactions and were monospecific by radial immunodiffusion assays against human plasma, human epidermal cell extracts, purified human plasma FN, and purified mouse LM. In addition, immunoblots with anti-FN against reduced human plasma and human epidermal cell extracts after 5% SDS-PAGE showed only one band at 220,000 and 250,000, respectively, the molecular weights for monomeric plasma and cellular FN. Monoclonal antibodies were prepared to various FN domains as previously described (28) . Polyclonal antibodies to human FG were purchased from Cappel Laboratories (Cochranville, PA).
Results
Adherent rat lung cell isolates were characterized as to cell type and degree of spreading at 3, 6 and 24 h after plating into fibronectin-coated microtiter wells (Fig. 1) . We used the modified Papanicolaou stain (29) to identify type II cells (14) and rabbit anti-keratin antibodies, kindly provided by T.-T. Sun, Department of Biochemistry, New York University, to identify epithelial cells (30, 31) . As shown in Fig. 1 (Fig. 1 A) but they showed marked increased spreading by 24 h (Fig. 1  G) . The kinetic response of type II cell adherence to bacteriologic plastic coated with FN, laminin, types I and III collagen, or type IV collagen, all at 100 ,g/ml, followed by HSA at 20 mg/ml or HSA alone at 20 mg/ml is shown in Fig. 2 (Fig. 3 A) . Since many more cells adhered to FN adsorbed directly to plastic than to FN/I, III collagen or FN/IV collagen substrates, we examined whether the surface density of FN adsorbed directly to plastic was higher than the FN surface density ofFN/collagen substrata. Indeed, the FN surface density (nanograms per square millimeter) (as determined by a modified inhibition ELISA) on bacteriologic plastic rapidly increased as increasing FN concentrations (micrograms per milliliter) were added to precoat the wells while the FN surface density on type IV collagen coated wells was fixed at a low level for all FN concentrations added (Fig. 3  B) . Thus, type II cell adherence on FN and FN/IV collagen seemed to parallel the FN surface density of these two substrata ( Fig. 3 A and B) . In contrast, the FN surface density (nanograms per square millimeter) on types I and III collagen coated wells rapidly increased for increasing FN concentrations (micrograms per milliliter) added, and yet type II cells adhered poorly to this substrate even at high FN surface densities ( Fig. 3 A and B ).
Type II cell adherence onto LM-coated, bacteriologic plastic, microtiter wells was quantitated in an identical fashion (Fig. 4  A) as the adherence of FN-coated wells described above (Fig. 3  A) . Very little type II cell adherence occurred to LM adsorbed directly to plastic or to LM/I, III collagen and LM/IV collagen substrates in spite of the fact that LM surface densities (nanograms per square millimeter) reached levels three times greater than FN surface densities (Figs. 4 B and 3 B, respectively) . Even when calculated on a molar basis laminin reached surface densities 1.5 times greater than FN. To further compare type II cell interactions with FN and LM substrata, we examined the degree of cell spreading on these two substrates at 6, 24, and 48 h after plating (Fig. 5) . Type II cells consistently spread much more slowly on LM-coated surfaces than on FN.
To test whether type II cell adherence to FN was a specific phenomenon, antibody inhibition experiments were performed. For these assays polyclonal antibodies to FN, LM, and FG were individually incubated with FN-, LM-, or FG-coated microtiter wells overnight at 4°C. Cell adherence was assayed the next day immediately after the plates containing antibodies were washed with PBS. As shown in Fig. 6 , antibodies to FN completely prevented type II cell adherence to FN-coated wells, whereas they did not affect cell adherence to LM-or FG-coated wells. Conversely, antibodies to LM or FG totally blocked cell adhesion to LM and FG, respectively, but not to the other substrates (Fig. 6 ).
When short incubation times (3 h) were used for cell adherence assays monoclonal antibodies (MoAb) to the fibroblastic cell-binding region (M3G) specifically blocked type II cell adherence to FN while MoAb to other FN domains did not ( Fig.  7 A and B) . During longer incubation times (24 h ) no MoAb appeared to interfere with cell adherence (Fig. 7, Cand D) . Like- wise, polyclonal anti-FN antibodies (1-44) had more capacity to inhibit adherence when the adherence assay was incubated for a short time or when the wells were coated with less concentrated MoAb were preincubated with the protein-coated wells and then washed just prior to assay (data not shown); therefore, all experiments illustrated in Fig. 7 were done with MoAb preincubation of microtiter plates plus coincubation with the cells during the adherence assay. Both time and preincubation constraints on monoclonal antibody inhibition experiments serve to exemplify the decreased capacity of MoAb to interfere with functional assays compared with polyclonal antibodies.
Discussion
Rat type II cells adhere (Fig. 2) and spread (Fig. 1 assays, showed a 40-60% reduction in adherence whether the cells were plated on FN, LM, or types I and III collagen (data not shown). Thus Fig. 3 A, typeII cells adhered increasingly well to plastic coated with increasing concentrations of FN. This correlated well with increasing FN surface densities (Fig. 3 B) . Likewise, the lack of type II cell adherence to plates coated with FN/ type IV collagen (Fig. 3 A) correlated well with low FN surface densities at all concentrations of FN used to precoat the plates (Fig. 3 B) .
Interestingly, there was a disparity between the poor type II cell adherence and the increasing FN surface densities on type I and III collagen seen with increasing FN concentrations used to coat the plates (Fig. 3 B) . Even though FN molecules were available on the plate surface, the FN cell-binding domain ( is probably less sensitive than a polyclonal antibody based ELISA secondary to only one antibody binding per protein antigen in the former compared to multiple antibodies binding per protein antigen in the latter.
Type II cells adhered poorly on all LM coated surfaces (Fig.   4 A), even at surface densities three to four times higher (Fig. 4 B) than FN surface densities (Fig. 3 B) that supported good adherence (Fig. 3 A) . These experiments thus suggest that there is an intrinsic difference in the ability of FN and LM to support type II cell adherence. The degree of type II cell spreading on FN-and LM-coated surfaces (Fig. 5) seems to parallel type II cell adherence on these protein substrata (Figs. 3 A and 4 A) . Type II cells are greatly spread on FN by 24 h (Fig. 5 A) , whereas they are spread to a much lesser degree on LM at this time (Fig. 5 C) . In fact, the degree of type II cell spreading on LM at 24 h (Fig. 5 C) is more comparable to the degree of spreading on FN at 6 h (Fig. 1 E) . By 48 h type II cells are well spread on LM-coated surfaces (Fig.  5 D) but the cells still show greater spreading on FN (Fig. 5 B) .
Specificity of type II cell adherence on FN, LM, and FG is illustrated in Fig. 6 by cross-blocking experiments with antibodies to these proteins. In addition, type II cell adherence on FN was dependent on the fibroblast cell-attachment domain as determined by blocking studies with a monoclonal antibody to this determinant (Fig. 7) . Previous studies have localized fibroblast attachment to FN to an 1 l-kD domain that is two-thirds the distance from the amino-terminus toward the carboxy terminus ofthe molecule (35, 36) . Monoclonal antibodies to other regions of the molecule failed under all assay conditions to inhibit type II cell adherence to FN (Fig. 7) . Thus, it appears that epithelial cells as well as fibroblasts may attach to FN at the same molecular domain.
In some previous studies (10) (11) (12) et aL. (41) address this apparent paradox. It appears that the order in which epidermal cells are exposed to fibronectin and a surface greatly affects their ability to spread. That is, if the cells are added to a substrate containing fibronectin or a medium containing fibronectin and then a surface they will spread (41), but if the cells are exposed to fibronectin after they attach to a surface, they will not spread (12) . Other epithelial cells have been shown to adhere and spread on fibronectin substrates, including hepatocytes from both the rat (42, 43) and the mouse (44), rabbit intestinal epithelial cells (45) , and human amnion epithelial cells (46) . Rat alveolar type II cells are quite unlike epidermal cells but quite like hepatocytes in that they adhere to low (2-5 jg/ml) concentrations of adsorbed FN. Like type II alveolar epithelial cells, human amnion epithelial cells (46) and human epidermal cells (47) have been recently observed to spread on both FN and collagen substrates whereas they show incomplete spreading on laminin (47) . Using a phagokinetic assay, O'Keefe et al. (47) demonstrated that the ability of epidermal cells to spread appeared to be related to their ability to migrate. We believe that plating type II cells onto protein coated microtiter wells more closely represents the reepithelialization process of postalveolar injury, such as occurs in the adult respiratory distress syndrome, than epithelial adhesion to basement membrane (BM) for several reasons: (a) the protein coats in these experiments provide a rather simple matrix more like an injured alveolar surface (5) rather than the complex, highly ordered BM (48) 
